Espresso Capital

Espresso Capital is a venture debt firm that offers non-dilutive financing to technology and healthcare companies, enabling them to accelerate growth and enhance strategic flexibility. Since its inception in 2009, Espresso has partnered with over 300 companies across the United States, Canada, and the United Kingdom, providing tailored credit structures to meet specific needs, including growth extensions, working capital, and acquisitions. Their founder-friendly approach emphasizes speed, fairness, and flexibility, ensuring a seamless experience for their clients.

The firm's investment strategy focuses on providing flexible credit structures such as unitranche and second lien loans, non-amortizing facilities, operating lines, and term loans with terms up to five years. They also offer warrant-free options, catering to the unique requirements of each business. Espresso's commitment to understanding the distinct dynamics of each company has earned them a reputation as a trusted partner among CEOs and financial leaders in the industry.

Espresso Capital's track record includes significant transactions, such as a $200 million credit facility secured in November 2021, led by KeyBank, which expanded their capacity to support high-growth technology and healthcare companies. Their portfolio features a diverse range of companies, including Akka, Nue, and Vidrio Financial, demonstrating their ability to provide substantial financing solutions that drive growth and innovation in various sectors.